welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy

key information

study id #: NCT03400852

condition: Muscular Dystrophy, Duchenne

status: terminated


This is a multicenter, double blind, placebo controlled, multiple dose study to examine the safety and efficacy of MNK-1411 in male subjects 4 to 8 years of age (inclusive) with Duchenne Muscular Dystrophy (DMD).

intervention: Cosyntropin, Placebo

mechanism of action: Melanocortin receptor agonist to reduce inflammation and muscle damage

results: https://clinicaltrials.gov/ct2/show/results/NCT03400852

last updated: August 26, 2020